3rd International Cancer Study & Therapy Conference
May 2-4, 2018 Rome, Italy
The State of Oncological Care and Ways of Improvement with Malignant Neoplasms in the Republic of North Ossetia-Alania in 1990-2014
P.A. Hertsen Moscow Oncology Research Center, Russia
The treatment of malignant neoplasms, despite the enormous successes in oncology, is the main problem of medicine and public health throughout the world
Purpose of the study: Analysis of the state of cancer care and ways to improve it in malignant tumors in the Republic of North Ossetia-Alania (RNO-Alania).
Materials and methods: Forms No. 7, No. 35, No. 5 (Table No. C51), Table 2 PH.
Results: The main indicators of oncological care for 43596 patients with malignant neoplasms were analyzed. Active detection of patients averaged 8.6%. At averaged 5-year intervals, it corresponded to: 1990-1994. - 6.7%, 1995-1999. - 7.6%, 2005-2009. - 9.4%, 2000-2004 - 10.1%, 2010-2014. - 9.0%, i.e. Has grown in 1,3 times. The diagnosis was verified morphologically in 82.7%. In the last 5-year period (80.1%) compared with the first (75.2%), an improvement of 1.06 times. In the early (I-II) stage, the disease was detected in 52.1%. In the last 5-year period (55.0%) compared with the first (50.6%), an improvement of 1.09 times. In the third stage, on average, 24.0%, in the last and first 5-year period 22.7% and 21.6%. In the IV stage, 23.8%, 22.2% and 23.8%, respectively. There is no improvement in these indicators. The contingent of patients on the register is 1349.6 per 100 000 population. In the last 5-year period (1913.3) compared with the first (949.2) increased by 2 times. However, an average of 51.8% is recorded on the account for 5 years and more, and the indicator of 5-year survival of the last period (52.9%) has not changed compared to the first (52.3%). That is, the growth of this indicator due to the increase in morbidity. In the first year after the diagnosis was established, 26.2% died. In the last 5-year period (24.2%) in comparison with the first (30.6%) decrease in 1.3 times. One-year mortality rate is 41.3%. The indicator of the last 5-year period (43.5%) compared to the first (42.7%) did not change. The number of patients who completed special treatment is 51.4%. The indicator of the last 5-year period (61.7%) compared to the first (44.2%) increased by 1.4 times. Of these, only surgical treatment is 18.6%. The indicator of the last 5-year period (20.4%) compared to the first (16.1%) increased by 1.3 times. Combined or complex treatment received 18.1%. In the last 5-year period (24.9%) compared to the first (12.8%), it increased 1.9 times. Chemoradiation treatment - 0,9%, only medicinal - 2,6%.
Conclusion: The indicators of active detectability and early detection of patients are low. Loss and mortality are high. A low percentage of surgical treatment and a survival rate of 5 years or more. The introduction of screening programs for cancer, increasing the oncological alertness of doctors of the treatment network and medical literacy of the population are mandatory.